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Background/aim: The nucleolus has the potential to provide insight into how many types of cancer will progress. In this study, we
examined the evaluation of the nucleolus with a microscope in widespread breast cancer tumors and whether this value contributes to
tumor grading as an objective clinicopathological parameter.
Materials and methods: In our study, the nucleolus was evaluated retrospectively in resections with a diagnosis of invasive breast
carcinoma of the cases between January 2010 and April 2021. In total, the tumor nucleolus of 377 cases of invasive breast carcinoma was
evaluated. Nucleolus evaluation was performed with light microscopy using four different modes (modified Helpap method, in 1, 5, and
10 high power fields at 40x magnification). The relationship between nucleolar scores and clinicopathological parameters was examined
separately. Regrading was performed by replacing nuclear pleomorphism with the nucleolar score in the classically used histological
grading system and utilizing the nucleolus score as the fourth parameter in this grading system.
Results: There was no significant correlation between the prognosis of the patients and the nucleolar score. When nuclear pleomorphism and nucleolar score were replaced in the classical grading system, disease-free and overall survival were correlated with the new
grading system. In addition, a relationship was found between high nucleolus score and other clinicopathological parameters (such as
estrogen receptor negativity, progesterone receptor negativity, high Ki-67, triple negative, and human epidermal growth factor receptor-2 status).
Conclusion: The presence of nucleolus is associated with disease-free survival and overall survival of patients, and it can be evaluated
with a light microscope at no extra cost and time. Therefore, in the classical grading, using it instead of nuclear pleomorphism with low
reproducibility among pathologists may provide more objective results in predicting patient prognosis.
Key words: Breast cancers, nucleolus prominence, light microscopy

1. Introduction
Breast cancer (BC) is still the most common cause of
cancer death in women worldwide, despite the newly
developed treatment methods and the knowledge of
tumor characteristics in many respects [1]. Histological
grade established by evaluating tubule formation,
mitosis, and nuclear pleomorphism, is one of the most
robust parameters, together with hormone receptors
and axillary lymph node involvement, in directing the
clinicopathological treatment of these tumors [2]. Among
these three parameters, nuclear pleomorphism has a
minor interobserver agreement [3,4].
In many tumors, especially the change in nucleolus
size and number is considered an indicator of malignancy
[5,6]. The first detailed study evaluating the relationship

between the nucleolus and cancer was done by Pianese
in 1896 [7]. Pianese performed a cytological analysis of
many malignant tumors and observed that a particularly
large nucleolus was present in the cancer cell nucleus.
In the early 20th century, several studies in cancer cells
confirmed the presence of very large nucleoli with broad
morphological changes [8]. MacCarty also made an
essential contribution to this issue by observing that “in
all malignant cells, regardless of the type or origin of the
neoplasm, the nucleolus is much larger than the size of the
nucleus” [9]. The leading role of the nucleolus, which is
closely related to cancer growth, is the synthesis of rRNA
and the assembly of ribosomal subunits [10–12]. The
increase in nucleolus size and number indicate a high
rate of ribosome biogenesis required for cell growth and
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proliferation [13,14]. Changes in the nucleolus are related
to epidermal growth factor, c-myc protein, and oncogene
proteins, which induce cell proliferation [15,16]. In
standard tissue samples, nucleoli are prominent stained by
eosin in hematoxylin & eosin stained preparations due to
their very high protein content [11]. Nucleolar evaluation
has been performed with silver staining of argyrophilic
nucleolar regulatory regions in many studies [8,17].
Nucleolus prominence in various tumors, including BC,
is accepted as an indicator of poor prognosis [5,18]. Today,
besides the putative clinicopathological parameters in BCs,
evaluation of the nucleolus is advocated as a parameter
that will provide prognostic benefit to the patients [5].
Elsharawy et al. have done the most extensive study on
this subject in the literature [5]. Nuclear pleomorphism
assessment, which is a parameter of the currently used
grading system, differs among the observers. Therefore, in
order to determine a new and more objective criterion in
tumor grading, in the current study, we evaluated nucleolar
prominence in invasive BCs diagnosed in our clinic.
In addition, we reviewed the relationship of nucleolar
prominence with prognostic and other clinicopathological
parameters. Ultimately, we examined whether taking the
nucleolar score as a parameter in the histological grading
system would contribute to predicting the prognosis.
2. Materials and methods
2.1. Patients and tissues
We selected patients with invasive BC who were operated
on in our general surgery department between January
2010 and April 2021 from our hospital database. In our
study, the nucleolus was evaluated retrospectively. In total,
tumor nucleolus of 377 cases of invasive breast carcinoma
were evaluated. Three hundred and fifty-five of the patients
were diagnosed with invasive carcinoma (invasive ductal
carcinoma, invasive lobular carcinoma), and 32 of them
were diagnosed with other specified histological types
(tubular, medullary, papillary, etc.). Patients whose clinical
data could not be accessed, who died immediately after
surgery due to operative complications, were excluded
from follow-up for any reason, did not have hematoxylin

& eosin slides, and formalin-fixed paraffin blocks in our
archive were excluded from the study.
Clinical information, including gender, age,
histological tumor type, grade, tumor size, lymph node
status, surgery type, and patient follow-up information,
was obtained through the hospital automation system.
All cases were divided into molecular subtypes according
to estrogen receptor (ER), progesterone receptor (PR),
human epidermal growth factor receptor-2 (HER2),
and Ki-67 immunohistochemical staining patterns and
histological types according to World Health Organization
(WHO) BC classification [19].
As a result, 377 patients were included in the study.
The nucleolus in tumor cells was evaluated with different
methods, and their relationship with clinicopathological
parameters, disease-free survival (DFS), and overall
survival (OS) were reviewed.
Please provide concise but complete information about
the materials and the analytical and statistical procedures
used. This part should be as clear as possible to enable
other scientists to repeat the research presented. Brand
names and company locations should be supplied for all
mentioned equipment, instruments, chemicals, etc.
2.2. Histopathological evaluation
In this study, hematoxylin& eosin stained preparations
of formaldehyde-fixed paraffin-embedded blocks (N =
377) were evaluated. Nucleolar prominence was assessed
with a conventional light microscope (Olympus, BX51, Olympus Corporation Tokyo, Japan, ocular 22mm)
using four different methods as in the study of Elsharawy
[5], with the modified Helpap method [20], we divided
the nucleolus count into three points according to their
prominence. A score of 1 was assigned to nucleolus that
was not prominent in any way (i.e. inconspicuous) or
nucleolus that was difficult to see at 20x magnification.
Nucleolus was scored three if prominent nucleolus or
dysmorphic/multiple nucleoli were present, easily seen
at 10x magnification, and identified in at least 20% of the
tumor. A score of 2 was assigned to nucleolus that was not
evaluated as a score of 1 or 3 (Figure 1; a: score 1, b: score
2, c: score 3).

Figure 1. Examples of nucleolus scores 1, 2, and 3 in one high power fields. Hematoxylin & eosin x400. (a: score 1, b:
score 2, c: score 3).
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To increase objectivity, nucleolus was also scored at
40x magnification. Nucleolus in areas of one, five, and ten
high power fields (HPFs) was scored as 1, 2, 3 according to
the cut-off values determined (Table 1).
All evaluations were made together by two pathologists
(SDÖ, ÇÖ) under a double-headed microscope. In cases
where no consensus could be reached, a third pathologist’s
opinion was obtained (OO).
The significance of the new histological grading
(NHG1), which was formed by replacing the nuclear
grade, a parameter of the histological grading used as a
standard, with the nucleolus score, was examined (NHG2)
(Table 2) [5].
2.3. Statistical analysis
Statistical analyses were performed by using IBM SPSS
Statistics, Version 21.0 (IBM SPSS Statistics; IBM Corp.,
Armonk, NY). Descriptive statistics of the groups were
given as frequencies and percentages (n, %). Before
analyzing numerical variables between NHG1 and
NHG2, normality analyses were performed (KolmogorovSmirnov and Shapiro-Wilk tests). Then, variables were
reported as mean ± standard deviation or median (minmax) accordingly. The association between nucleolus
score and clinicopathological variables was evaluated
with the chi-square (Pearson chi-square, linear-by-linear
association) and Fisher’s exact test, considering the
number of patients in the categories. Prognostic factors
affecting overall survival and disease-free survival were
determined by univariate and multivariate Cox regression

analysis. Variables with p < 0.2, which were determined by
univariate analyses selected as covariates and were analyzed
using the backward method. The effects of variables on
survival were evaluated with the Kaplan Meier survival
analysis and log-rank test. For statistical significance, the
p-value was accepted as <0.05.
3. Results
3.1. Nucleolus prominence and clinicopathological
parameters
Tumor
nucleolus
prominence
was
evaluated
histopathologically in 377 women patients. The median age
of the patients was 56 (25–100) years, and the mean followup period was 48 (2–136) months. Three hundred and fiftyfive of the patients were diagnosed with invasive carcinoma
(invasive ductal carcinoma, invasive lobular carcinoma), and
32 of them were diagnosed with other specified histological
types (tubular, medullary, papillary, etc.).
According to molecular subtypes, 151 patients were
evaluated as luminal A, 177 patients as luminal B, 28
patients as Her2, and 31 as triple-negative.
Evaluated with a light microscope at 20x magnification,
the number of patients with nucleolus score 1 was 177, the
number of patients with score 2 was 109, and the number
of patients with score 3 was 101 (Table 3). There were
significant differences among nucleolus scores for ER
negativity, PR negativity, and high Ki-67 (p = 0.006, p =
0.042, p < 0.001, respectively). These parameters are also
detailed in Table 3.

Table 1. Cut-off points of nucleolus count suggested by Elsharawy et al [5].
Parameters

Definitions of nucleolus count
Score 2

Score 3

Nucleolus count in 10 HPFs* (at 40x) 0–4

Score 1

5–101

>101

Nucleolus count in 5 HPFs (at 40x)

0–2

3–50

>50

Nucleolus count in 1 HPFs (at 40x)

0

1–9

>9

* High power field
Table 2. Incorporation of nucleolar scores into the histological grading system.
Groups

Total Scores

Equivalent grade

NHG1*: Grade after replacing nuclear Total score 3, 4
pleomorphism score with nucleolus Total score 5, 6
score
Total score 7, 8, 9

Grade 1

NHG2*: Grade after adding nucleolus Total score 4, 5, 6
score to the other three components Total score 7, 8, 9
of the grade
Total score 10, 11, 12

Grade 1

Grade 2
Grade 3
Grade 2
Grade 3

*NHG: New histological grade.

977

DUMAN ÖZTÜRK et al. / Turk J Med Sci
Table 3. The relationship between the nucleolus score (by Modified Helpap’s method) and other clinicopathological parameters.
Nucleolus score

Diagnosis
Estrogen receptor
Progesterone receptor

Her 2

Ki-67

Molecular subtypes

Nuclear grade

Histologic grade

Multicentricity

Tumor size

Perineural Invasion
Angiolymphatic Invasion
Lymph node
Metastasis
Death

978

1

2

3

n (%)

n (%)

n (%)

p

Invasive Carcinoma (IC)

159 (89.8)

101 (92.7)

95 (94.1)

0.43

Others

18 (10.2)

8 (7.3)

6 (5.9)

Negative

21 (11.9)

17 (15.6)

27 (26.7)

Positive

156 (88.1)

92 (84.4)

74 (73.3)

Negative

42 (23.7)

29 (26.6)

38 (37.6)

Positive

135 (76.3)

80 (73.4)

63 (62.4)

0

95 (53.7)

53 (48.6)

44 (43.6)

1

23 (13)

19 (17.4)

16 (15.8)

2

28 (15.8)

13 (11.9)

12 (11.9)

3

31 (17.5)

24 (22)

29 (28.7)

Low

89 (50.3)

52 (47.7)

28 (27.7)

High

88 (49.7)

57 (52.3)

73 (72.3)

Luminal A

77 (43.5)

46 (42.2)

28 (27.7)

Luminal B

81 (45.8)

48 (44)

48 (47.5)

HER2

9 (5.1)

9 (8.3)

10 (9.9)

Triple Negative

10 (5.6)

6 (5.5)

15 (14.9)

1

47 (26.6)

21 (19.3)

1 (1)

2

118 (66.7)

71 (65.1)

73 (72.3)

3

12 (6.8)

17 (15.6)

27 (26.7)

1

17 (9.6)

10 (9.2)

6 (5.9)

2

141 (79.7)

82 (75.2)

68 (67.3)

3

19 (10.7)

17 (15.6)

27 (26.7)

Negative

152 (85.9)

90 (82.6)

91 (90.1)

Positive

25 (14.1)

19 (17.4)

10 (9.9)

T1

76 (42.9)

44 (40.4)

38 (37.6)

T2

95 (53.7)

58 (53.2)

53 (52.5)

T3

6 (3.4)

7 (6.4)

10 (9.9)

Negative

122 (68.9)

82 (75.2)

79 (78.2)

Positive

55 (31.1)

27 (24.8)

22 (21.8)

Negative

92 (52)

53 (48.6)

54 (53.5)

Positive

85 (48)

56 (51.4)

47 (46.5)

Negative

94 (53.1)

59 (54.1)

59 (58.4)

Positive

83 (46.9)

50 (45.9)

42 (41.6)

Negative

152 (85.9)

95 (87.2)

86 (85.1)

Positive

25 (14.1)

14 (12.8)

15 (14.9)

Negative

149 (84.2)

99 (90.8)

86 (85.1)

Positive

28 (15.8)

10 (9.2)

15 (14.9)

0.006
0.042
0.311

0.001
0.021

<0.001

0.014

0.289
0.276

0.205
0.766
0.685
0.912
0.263
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In nuclear grade evaluation simultaneously in the same
patient group; there were 124 patients with grade 1, 213
patients with grade 2, and 50 patients with grade 3. The
nuclear grade of the cases was primarily clustered in grade
2. When the nucleolus scoring and nuclear grade were
compared, nucleolus scores were significantly concordant
with nuclear grades (p < 0.001).
3.2. Relation of nucleolus evaluation with prognosis
By Kaplan Meier analysis, it was found that NHG1, in
which the nucleolus score and nuclear grade were replaced,
was associated with overall survival (Log-rank p = 0.039)
(Figure 2) and disease-free survival (Log-rank p = 0.001)
(Figure 3). According to this, the mean life expectancy of
grade 3 cases was found to be shorter than grade 1 and 2
cases (grade 3 mean survival 101.6 months). In terms of
disease-free survival, similarly, high-grade patients had a
worse DFS than low-grade patients (grade 3 mean diseasefree survival 98.4 months).
DFS was found to be associated with NHG2, in which
the nucleolus score was added as the fourth parameter

(grade 3 mean disease-free survival 104.3 months).
Although the mean life expectancy of grade 3 cases was
shorter, it was not statistically significant (Log-rank p =
0.064).
When the relationship of the variables with OS was
evaluated, in univariate analysis, metastasis, age, PR, Ki67, molecular subtype, tumor diameter, angiolymphatic
invasion, lymph node metastasis were associated with
OS. In contrast, nucleolus score and nuclear grade were
not associated with OS (Table 4). In multivariate analysis,
molecular subtype, metastasis, age, and lymph node
metastasis were determined as independent predictive
variables for OS (Table 5).
When the relationship of the variables with DFS was
evaluated, in the univariate analysis, molecular subtype,
age, PR, Ki-67, tumor diameter, angiolymphatic invasion,
lymph node metastasis, nucleolus score (10 HPFs) were
associated with DFS. In multivariate analysis, Ki-67, tumor
diameter, and lymph node metastasis were determined as
independent predictive variables for DFS.

Table 4. Risk factors associated with OS in cox regression model.
Univariate analysis

Multivariate analysis

p

p

HR (95% Cl)

Molecular subtypes (triple negative vs. luminal A)

<0.001

0.002

3.904 (1.682–9.06)

Nuclear grade (3 vs. 1)

0.581

Nucleolus score (3 vs. 1)

0.952

Nucleolus score 1 HPF*(3 vs. 1)

0.498

Nucleolus score 5 HPFs (3 vs. 1)

0.360

Nucleolus score 10 HPFs (2 vs. 1)

0.009

Age

<0.001

0.001

1.058 (1.036–1.079)

Histopathologic type

0.709

Estrogen receptor

0.013

Progesterone receptor

0.080

Her 2 (3 vs. 1)

0.564

Ki-67

0.005

HG** (3 vs. 1)

0.175

NHG1*** (3 vs. 1)

0.389

Multicentricity

0.531

Tumor size (3 vs. 1)

<0.001

Perineural invasion

0.309

Angiolymphatic invasion

<0.001

Lymph node

<0.001

0.017

2.355 (1.163–4.77)

Metastasis

<0.001

<0.001

4.468 (2.466–8.095)

*HPF: High power field. **HG: Histological grade. ***NHG: New histological grade.
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Figure 2. By Kaplan Meier analysis, it was found that NHG1, in
which the nucleolus score and nuclear grade were replaced, was
associated with overall survival.

Figure 3. By Kaplan Meier analysis, it was found that NHG1, in
which the nucleolus score and nuclear grade were replaced, was
associated with disease free survival.

Table 5. Risk factors associated with DFS in cox regression model.
Univariate

Multivariate

p

p

HR (95% CI)

0.068

1.018 (0.999–1.037)

0.001

3.038 (1.552–5.945)

0.028

3.059 (1.13–8.281)

0.001

3.059 (1.644–5.69)

Nuclear grade (3 vs. 1)

0.407

Nucleolus score (3 vs 1)

0.824

Nucleolus score 1 HPF* (3 vs. 1)

0.624

Nucleolus score 5 HPFs (3 vs. 1)

0.645

Nucleolus score 10 HPFs (3 vs 1)

0.688

Age

0.061

Histopathologic type

0.243

Estrogen receptor

0.138

Progesterone receptor

0.006

Her 2 (3 vs. 0)

0.682

Ki-67

0.001

Molecular subtypes (triple negative vs. luminal A) 0.001
HG** (3 vs. 1)

0.046

NHG1*** (3 vs. 1)

0.279

Multicentricity

0.095

Tumor size (3 vs. 1)

0.004

Perineural invasion

0.287

Angiolymphatic invasion

0.001

Lymph node

0.001

*HPF: High power field. **HG: Histological grade.***NHG: New histological grade.

4. Discussion
Breast cancer is one of the most common malignancies
among women worldwide and is the leading cause of
most cancer-related deaths [21]. Despite increased early
diagnosis methods and knowledge about breast cancer
biology, recurrence is still seen in breast cancer cases. The
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carcinomas; made nucleolus grading by determining the
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frequency and localization of nucleolus [20]. He later used
the nucleolus grading for prostate cancers as well [22].
The nucleolus, a parameter that can be evaluated by the
Helpap method, is a crucial cell component that reflects
the growth and increases. The increase in nucleolus
prominence can be related to how much protein the cell
needs. Changes in the nucleolus of cancer cells, which are
very important for human life (nucleolus growth, shape
differences), are indicators of poor prognosis [5,11,23,24].
Despite being so valuable, there is no consensus on the
histopathological evaluation of the nucleolus in BCs. The
most optimal study evaluating the nucleolus in breast
carcinomas belongs to Elsharawy, K.A., and his friends
[5].
In Elsharawy et al.’s study in 2020, 1200 validation,
400 training sets, and nucleolus evaluation on slides
completely digitized were evaluated with four different
methods: modified Helpap method, 1, 5, and 10 HPFs.
The most objective method was determined as the
nucleolus counted in 5 HPFs, and they showed that it
was significantly associated with breast cancer-specific
survival (BCSS) (p < 0.001). The high nucleolus score was
associated with younger age, larger tumor size, and higher
grade. They found that the inclusion of the nucleolus
score in the Nottingham grading system showed a higher
significant association with survival than the classical
grading. This study gave rise to hope in terms of being a
new parameter in grading.
Since some tumors have a heterogeneous morphology,
it is necessary to evaluate different areas. For this reason,
although it is more reliable to assess the entire tumor area
with digitalized methods, it is not easy to reach these
methods in the routine pathology practice. For this reason,
while determining the nucleolus in our study, different
numbers of field views were examined from the areas
defined as hot spots, as in the study of Elsharawy.
In our study, nucleolus score was found to be associated
with clinicopathological parameters such as ER, PR, Ki67, molecular subtypes. Based on this, the correlation of
nucleolus score with clinicopathological parameters such
as ER and PR negativity, which are associated with some
other poor prognosis, may be a sign of poor prognosis.
However, it was not found to be related to the survival of
patients alone.
Nucleolus prominence, assessed using the modified
Helpap method, was reevaluated in 1, 5, and 10 HPFs.
When we substituted the nuclear pleomorphism in the
histological grade calculated by determining tubule
formation, nuclear pleomorphism and mitosis number
used in classical grading, and nucleolus scoring, a
statistically significant correlation was found for OS and
DFS. Survival of those with NHG 1 high grades was
significantly shorter.

Nuclear pleomorphism reflects the shape, chromatin
distribution, and size of the nucleolus [5]. There are
no established grading criteria to evaluate nuclear
pleomorphism. Therefore, this parameter, which is a
very subjective criterion, leads to different results among
pathologists. The minor agreement was observed for
histological grade parameters among pathologists in
several studies [25–28].
The lack of clear definitions and reproducibility of this
grading criterion is a powerful reason to replace it with
more objective components. Compared to this, nucleolus
evaluation with the Modified Helpap method can be
considered as a more accurate and even-handed parameter.
At the same time, besides this method, nucleolus evaluation
can be calculated with a light microscope with cut-off
values determined with 1, 5, and 10 HPFs, while this is not
the case for nuclear pleomorphism. In this sense, accepted
evaluation methods for the nucleolus are relatively more
objective.
OS and DFS were found to be significant with the new
histological grade formed when nuclear pleomorphism
and nucleolus score were displaced. Accordingly, as the
new histological grade increased, OS and DFS shortened.
Therefore, the nucleolus score is promising as an objective
parameter of grading rather than as a stand-alone criterion.
Today, digital pathology is becoming more and more
common, and we know that it has become a more objective
option for pathological preparation evaluation. Elsharawy
et al. also worked digitally, but this system was neither
cost-effective nor practical. In our study, evaluation was
made with light microscopy, and the results were found
to be associated with prognosis. It is both functional and
low-cost work.
There were some limitations in our article, our cases
did not have a homogeneous distribution according to
menopausal status, histological type, molecular subtype
and age data. Some of the cases had a short follow-up
period.
In conclusion, due to the low agreement among
pathologists in the classical grading system, there is a
need for a more objective parameter in grading. For this
reason, nucleolar prominence, which can be easily and
quickly evaluated with light microscopy without extra cost
and time, and whose relationship with prognosis has also
been proven in our study, can be used instead of nuclear
pleomorphism in grading.
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